NuGen Medical Devices Inc.
NGMDF
$0.02
$0.00-1.89%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 68.67% | -175.10% | 19.43% | -254.19% | 199.29% |
| Total Depreciation and Amortization | -16.59% | 16.57% | 3.97% | 7.83% | -2.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -89.39% | 466.33% | -47.51% | 159.78% | -74.02% |
| Change in Net Operating Assets | 126.56% | 3.98% | -176.76% | 152.83% | 91.88% |
| Cash from Operations | -2.88% | 7.96% | -49.14% | 10.12% | 71.37% |
| Capital Expenditure | -71.23% | -128.15% | -42.82% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -19,100.00% | 75.00% | -- | -- | -- |
| Cash from Investing | -101.68% | -125.23% | -44.91% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -85.06% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -100.00% | -85.41% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.77% | -1.06% | -48.88% | -4.25% | 69.13% |